ECSP941143A - Indoles - Google Patents

Indoles

Info

Publication number
ECSP941143A
ECSP941143A EC1994001143A ECSP941143A ECSP941143A EC SP941143 A ECSP941143 A EC SP941143A EC 1994001143 A EC1994001143 A EC 1994001143A EC SP941143 A ECSP941143 A EC SP941143A EC SP941143 A ECSP941143 A EC SP941143A
Authority
EC
Ecuador
Prior art keywords
graph
alkyl
indoles
co2r12
tetrazol
Prior art date
Application number
EC1994001143A
Other languages
English (en)
Inventor
David James Rawson
Graham Nigel Maw
Julian Blagg
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of ECSP941143A publication Critical patent/ECSP941143A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/307—Compounds having groups having acetal carbon atoms bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/313—Compounds having groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/784—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic with all keto groups bound to a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Un compuesto de la fórmula (I) (gráfico), 10 y sus sales de base farmacéuticamente aceptables, en la que: R es CO2R12, donde R12, es H o un grupo que forma un éster biolábil, o R es tetrazol-5-ilo, y bien (A) R1 es (gráfico), y R2 es F,Cl, Br, I, CH3 o CF3 o (b) R1 es alquilo de C3-C6 y R2 es alquilo de C2-C4.
EC1994001143A 1993-08-17 1994-08-17 Indoles ECSP941143A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939317096A GB9317096D0 (en) 1993-08-17 1993-08-17 Indoles

Publications (1)

Publication Number Publication Date
ECSP941143A true ECSP941143A (es) 1995-01-16

Family

ID=10740625

Family Applications (1)

Application Number Title Priority Date Filing Date
EC1994001143A ECSP941143A (es) 1993-08-17 1994-08-17 Indoles

Country Status (18)

Country Link
US (1) US5912357A (es)
EP (1) EP0714390B1 (es)
JP (1) JP2833865B2 (es)
AT (1) ATE188695T1 (es)
AU (1) AU7497794A (es)
CA (1) CA2167397C (es)
CO (1) CO4290297A1 (es)
DE (1) DE69422629T2 (es)
DK (1) DK0714390T3 (es)
EC (1) ECSP941143A (es)
ES (1) ES2140552T3 (es)
FI (1) FI960730A0 (es)
GB (1) GB9317096D0 (es)
GR (1) GR3032845T3 (es)
IL (1) IL110627A0 (es)
PE (1) PE16695A1 (es)
PT (1) PT714390E (es)
WO (1) WO1995005375A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
FR2796274B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2796279B1 (fr) 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
GB9115951D0 (en) * 1991-07-24 1991-09-11 Pfizer Ltd Indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles

Also Published As

Publication number Publication date
AU7497794A (en) 1995-03-14
EP0714390B1 (en) 2000-01-12
ES2140552T3 (es) 2000-03-01
CA2167397A1 (en) 1995-02-23
US5912357A (en) 1999-06-15
CO4290297A1 (es) 1996-04-17
FI960730A (fi) 1996-02-16
JP2833865B2 (ja) 1998-12-09
FI960730A0 (fi) 1996-02-16
EP0714390A1 (en) 1996-06-05
PT714390E (pt) 2000-06-30
DE69422629T2 (de) 2000-06-29
GB9317096D0 (en) 1993-09-29
IL110627A0 (en) 1994-11-11
JPH09500142A (ja) 1997-01-07
WO1995005375A1 (en) 1995-02-23
CA2167397C (en) 2000-12-12
PE16695A1 (es) 1995-06-21
GR3032845T3 (en) 2000-07-31
ATE188695T1 (de) 2000-01-15
DE69422629D1 (en) 2000-02-17
DK0714390T3 (da) 2000-05-01

Similar Documents

Publication Publication Date Title
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
ES2058653T3 (es) Inhibidor de proteinasas.
FI973217A (fi) Heteroaromaattisella renkaalla substituoituja antimikrobiaalisia fenyylioksatsolidinoniyhdisteitä
ES2127397T3 (es) Sulfonamidas y sus derivados que modulan la actividad de la endotelina.
ES529054A0 (es) Procedimiento para la obtencion de derivados de dibenzoil-metano
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ATE179173T1 (de) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy 1,3-propandiol-derivate
ES2098357T3 (es) Derivado de indol.
CO4700523A1 (es) Purin-6-onas bisustituidas en 2,9
SV2002000244A (es) Metodos y compuestos para inhibir mrp1 ref.x-13353
ATE149164T1 (de) Neue tetrazolderivate, verfahren zu ihrer herstellung und ihre verwendung
ECSP941143A (es) Indoles
AR247729A1 (es) Procedimiento para preparar nuevos compuestos antiarritmicos
BR9104888A (pt) Inibidor e processo para inibicao de polimerizacao de um composto vinila
PL290676A1 (en) Method of obtaining novel derivatives of 2-aminoalkyl-5-diaryl-alkyl-1.3-dioxane
CO5070565A1 (es) Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido y sus composiciones farmaceuticas
CO4970804A1 (es) Nuevos derivados de la vitamina d3
AR018675A1 (es) Derivados de 3-(2-oxo-[1,3¿i¿]bipirrolidinil-3-ilidenometil)-cefem, una composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento.
DK0668279T3 (da) 6-azaindol thromboxansytaseinhibitor
TW354294B (en) Substituted tetronic acids useful for treating HIV and other retroviruses
CO5011097A1 (es) Derivados de 8-azabiciclo [3.2.1]octan-3-metanamina .
FI963168A (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia indaani-2-merkaptoasetyyliamiddisulfidijohdannaisia
PE6691A1 (es) Tetrahidrobenzopiranopirazoles artropodicidas
ID26946A (id) Senyawa-senyawa baru
ES2111309T3 (es) Enantiomeros farmacologicamente activos.